AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Return
31.39%
This Quarter Return
-16.99%
1 Year Return
+31.39%
3 Year Return
+70.33%
5 Year Return
+145.91%
10 Year Return
–
AUM
$22.6B
AUM Growth
-$5.2B
(-19%)
Cap. Flow
+$704M
Cap. Flow
% of AUM
3.11%
Top 10 Holdings %
Top 10 Hldgs %
19.68%
Holding
2,461
New
137
Increased
1,389
Reduced
800
Closed
128
Top Buys
| 1 |
Amazon
AMZN
|
$72.9M |
| 2 |
Microsoft
MSFT
|
$40.7M |
| 3 |
CERN
Cerner Corp
CERN
|
$34M |
| 4 |
Gilead Sciences
GILD
|
$27M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
$25.5M |
Top Sells
| 1 |
PepsiCo
PEP
|
$44.4M |
| 2 |
Chevron
CVX
|
$31.9M |
| 3 |
Walt Disney
DIS
|
$24M |
| 4 |
Wells Fargo
WFC
|
$22.7M |
| 5 |
Bank of America
BAC
|
$20.9M |
Sector Composition
| 1 | Technology | 22.66% |
| 2 | Healthcare | 14.97% |
| 3 | Financials | 14.12% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Communication Services | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANH
2276
DELISTED
Anworth Mortgage Asset Corporation
ANH
| $53K | ﹤0.01% |
46,686
-87,484
| -65% | -$99.3K |
|
|
RUBY
2277
DELISTED
Rubius Therapeutics, Inc
RUBY
| $51K | ﹤0.01% |
+11,417
| New | +$51K |
|
|
ADAP
2278
Adaptimmune Therapeutics
ADAP
$10.9M
| $51K | ﹤0.01% |
+18,598
| New | +$51K |
|
2279
Rigel Pharmaceuticals
RIGL
$742M
| $50K | ﹤0.01% |
3,191
-427
| -12% | -$6.69K |
|
2280
TherapeuticsMD
TXMD
$12.5M
| $47K | ﹤0.01% |
892
-3
| -0.3% | -$158 |
|
2281
Nabors Industries
NBR
$560M
| $46K | ﹤0.01% |
2,354
-3,648
| -61% | -$71.3K |
|
|
GNMK
2282
DELISTED
GenMark Diagnostics, Inc
GNMK
| $42K | ﹤0.01% |
+10,174
| New | +$42K |
|
2283
Modine Manufacturing
MOD
$7.1B
| $40K | ﹤0.01% |
12,165
-16,984
| -58% | -$55.8K |
|
|
VRAY
2284
DELISTED
ViewRay, Inc.
VRAY
| $40K | ﹤0.01% |
+15,935
| New | +$40K |
|
|
JCP
2285
DELISTED
J.C. Penney Company, Inc.
JCP
| $39K | ﹤0.01% |
108,754
+24,230
| +29% | +$8.69K |
|
2286
Gold Resource Corp
GORO
$103M
| $38K | ﹤0.01% |
13,887
-289
| -2% | -$791 |
|
|
CHS
2287
DELISTED
Chicos FAS, Inc.
CHS
| $37K | ﹤0.01% |
28,752
-70,298
| -71% | -$90.5K |
|
2288
BioCryst Pharmaceuticals
BCRX
$1.74B
| $36K | ﹤0.01% |
17,872
+13
| +0.1% | +$26 |
|
2289
Chord Energy
CHRD
$5.92B
| $35K | ﹤0.01% |
100,169
-203,605
| -67% | -$71.1K |
|
|
BKCC
2290
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $34K | ﹤0.01% |
15,527
-8,194
| -35% | -$17.9K |
|
|
QEP
2291
DELISTED
QEP RESOURCES, INC.
QEP
| $33K | ﹤0.01% |
98,070
-127,096
| -56% | -$42.8K |
|
2292
McEwen Inc.
MUX
$734M
| $32K | ﹤0.01% |
4,884
-7,852
| -62% | -$51.4K |
|
|
SPPI
2293
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $31K | ﹤0.01% |
13,490
-2,182
| -14% | -$5.01K |
|
|
RRD
2294
DELISTED
RR Donnelley & Sons Co.
RRD
| $31K | ﹤0.01% |
32,348
+7,529
| +30% | +$7.22K |
|
2295
Garrett Motion
GTX
$2.64B
| $30K | ﹤0.01% |
10,403
-16,551
| -61% | -$47.7K |
|
2296
Abeona Therapeutics
ABEO
$353M
| $29K | ﹤0.01% |
552
-153
| -22% | -$8.04K |
|
2297
Clearside Biomedical
CLSD
$27.2M
| $27K | ﹤0.01% |
15,596
| – | – |
|
2298
Groupon
GRPN
$971M
| $27K | ﹤0.01% |
1,391
-311
| -18% | -$6.04K |
|
2299
Standard BioTools
LAB
$497M
| $27K | ﹤0.01% |
+10,579
| New | +$27K |
|
|
NPKI
2300
NPK International Inc.
NPKI
$887M
| $27K | ﹤0.01% |
30,042
-1,354
| -4% | -$1.22K |
|